Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BAC.

Johnson BA, Coutts M, Vo HM, Hao X, Fatima N, Rivera MJ, Sims RJ, Neel MJ, Kang YJ, Monuki ES.

Fluids Barriers CNS. 2018 Aug 16;15(1):22. doi: 10.1186/s12987-018-0107-4.

2.

Characteristics of the cerebrospinal fluid pressure waveform and craniospinal compliance in idiopathic intracranial hypertension subjects.

Okon MD, Roberts CJ, Mahmoud AM, Springer AN, Small RH, McGregor JM, Katz SE.

Fluids Barriers CNS. 2018 Aug 1;15(1):21. doi: 10.1186/s12987-018-0106-5.

3.

Pulsatile flow drivers in brain parenchyma and perivascular spaces: a resistance network model study.

Rey J, Sarntinoranont M.

Fluids Barriers CNS. 2018 Jul 16;15(1):20. doi: 10.1186/s12987-018-0105-6.

4.

Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.

Ramirez SH, Andrews AM, Paul D, Pachter JS.

Fluids Barriers CNS. 2018 Jul 1;15(1):19. doi: 10.1186/s12987-018-0104-7. Review.

5.

Is bulk flow plausible in perivascular, paravascular and paravenous channels?

Faghih MM, Sharp MK.

Fluids Barriers CNS. 2018 Jun 15;15(1):17. doi: 10.1186/s12987-018-0103-8.

6.

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

Hong B, Polemikos M, Heissler HE, Hartmann C, Nakamura M, Krauss JK.

Fluids Barriers CNS. 2018 Jun 4;15(1):16. doi: 10.1186/s12987-018-0101-x.

7.

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

8.

Zika virus crosses an in vitro human blood brain barrier model.

Alimonti JB, Ribecco-Lutkiewicz M, Sodja C, Jezierski A, Stanimirovic DB, Liu Q, Haqqani AS, Conlan W, Bani-Yaghoub M.

Fluids Barriers CNS. 2018 May 15;15(1):15. doi: 10.1186/s12987-018-0100-y.

9.

Nimodipine treatment does not benefit juvenile ferrets with kaolin-induced hydrocephalus.

Di Curzio DL, Mao X, Baker A, Del Bigio MR.

Fluids Barriers CNS. 2018 May 3;15(1):14. doi: 10.1186/s12987-018-0099-0.

10.

Fluid outflow in the rat spinal cord: the role of perivascular and paravascular pathways.

Liu S, Lam MA, Sial A, Hemley SJ, Bilston LE, Stoodley MA.

Fluids Barriers CNS. 2018 Apr 29;15(1):13. doi: 10.1186/s12987-018-0098-1.

11.

Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models.

Noumbissi ME, Galasso B, Stins MF.

Fluids Barriers CNS. 2018 Apr 23;15(1):12. doi: 10.1186/s12987-018-0097-2. Review.

12.

Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.

Lee CAA, Seo HS, Armien AG, Bates FS, Tolar J, Azarin SM.

Fluids Barriers CNS. 2018 Apr 4;15(1):9. doi: 10.1186/s12987-018-0094-5.

13.

Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop.

Koschnitzky JE, Keep RF, Limbrick DD Jr, McAllister JP 2nd, Morris JA, Strahle J, Yung YC.

Fluids Barriers CNS. 2018 Mar 27;15(1):11. doi: 10.1186/s12987-018-0096-3. Review.

14.

Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration.

Wang Q, Delva L, Weinreb PH, Pepinsky RB, Graham D, Veizaj E, Cheung AE, Chen W, Nestorov I, Rohde E, Caputo R, Kuesters GM, Bohnert T, Gan LS.

Fluids Barriers CNS. 2018 Mar 20;15(1):10. doi: 10.1186/s12987-018-0093-6.

15.

Cerebrospinal fluid protein and glucose levels in neonates with a systemic inflammatory response without meningitis.

Noureldein M, Mardare R, Pickard J, Shing HL, Eisenhut M.

Fluids Barriers CNS. 2018 Mar 14;15(1):8. doi: 10.1186/s12987-018-0095-4.

16.

Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation.

Katt ME, Linville RM, Mayo LN, Xu ZS, Searson PC.

Fluids Barriers CNS. 2018 Feb 20;15(1):7. doi: 10.1186/s12987-018-0092-7.

17.

Paradigm-shift: radiological changes in the asymptomatic iNPH-patient to be: an observational study.

Engel DC, Adib SD, Schuhmann MU, Brendle C.

Fluids Barriers CNS. 2018 Feb 9;15(1):5. doi: 10.1186/s12987-018-0090-9.

18.

Progress in brain barriers and brain fluid research in 2017.

Keep RF, Jones HC, Drewes LR.

Fluids Barriers CNS. 2018 Feb 2;15(1):6. doi: 10.1186/s12987-018-0091-8.

19.

The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma.

Jackson S, Weingart J, Nduom EK, Harfi TT, George RT, McAreavey D, Ye X, Anders NM, Peer C, Figg WD, Gilbert M, Rudek MA, Grossman SA.

Fluids Barriers CNS. 2018 Jan 15;15(1):2. doi: 10.1186/s12987-017-0088-8.

20.

Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbroucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M.

Fluids Barriers CNS. 2018 Jan 12;15(1):3. doi: 10.1186/s12987-017-0086-x.

Supplemental Content

Loading ...
Support Center